US Cosmetic Surgery Procedures Market to Reach $15.1 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Americans want to look young. It drives demand for cosmetic surgery, and the aesthetic procedures market is projected to reach $15.13 billion by 2012.

Injectables represent the most vibrant and promising growth area, since downtime and recovery period is minimal to nil and costs are easy-on-the-pocket. Surgical treatments, which provide long-term benefits, are temporality out-of-favor, especially since the US economic slowdown has tightened consumer spending on their expensive in nature, out-of-pocket surgical treatments.

Recent years have been glorious in the history of cosmetic surgery products and procedures, as new product approvals and technology improvements have strived to provide the best to the prospective patient. Although, slightly disturbed as a result on ongoing economic meltdown, long-term forecast promise nothing but a bright future. As the US population ages, and people have access to discretionary income, they are indeed expected to splurge on having a treatment, surgical or non-surgical. While it is always easier to get a shot of botox to smoothen wrinkles, or a dermal filler to plump up under eye hollows, demand for popular surgical treatments would continue with those for whom injections are not enough to get the desired look.

Leading growth would be non-surgical treatments: dermal fillers, injectables, laser treatments.

The US cosmetic surgery products market is home to large number of companies. However, due to the diverse nature of product categories (Equipment, Injectables and Implants), not all companies are active in all market segments. Key players include Allergan, Mentor, Medicis Pharmaceuticals, Dermik Laboratories, BioForm Medical, Artes Medical, Anika Therapeutics, Cutera, Lumenis, DermaMed USA, ExcellaDerm Corporation, Cynosure, Fascia Biosystems, Genesis Biosystems, Genzyme Corporation, Syneron, Thermage, Candela, IRIDEX Corp., Ortho-McNeil-Janssen Pharmaceuticals, Lumenis Ltd., Palomar Medical Technologies, Q-Med AB, and Solta Medical.

The report analyzes the US and the European markets in terms of both Cosmetic Surgery Products, and Cosmetic Surgery Procedures for the period 2006 through 2015. Major Cosmetic Surgery Products analyzed for the US market include Equipment (Lasers, Microdermabrators and Other Equipment), Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables), Implants (Breast Implants and Other Implants), and Other Markets. Cosmetic Surgery Procedures analyzed for the US market include Surgical (Breast Augmentation, Abdominoplasty, Blepharoplasty, Facelift, Liposuction, Rhinoplasty, and Others), and Non-surgical (Botox, Dermal Fillers, Laser Hair Removal, Laser Skin Resurfacing, Chemical Peel, Microdermabrasion, and Others). The European market is analyzed in terms of Cosmetic Procedures (Surgical and Non-surgical) by country for years 2008, 2010, and 2013. Select surgical procedures analyzed for the Europe region include Breast Augmentation, Liposuction, Blepharoplasty, and Rhinoplasty.

Full report is available for purchase from the publisher.

Bad economy is making patients more cost-conscious, and plastic surgeons, the elite corps of lavishly compensated surgeons are going to unheard-of lengths to drum up business.

Some are sending out discount coupons and offering payment plans. Others are turning to less expensive and less invasive procedures. And all of them have to actually market their aesthetic practices.

After many years of steadily growing demand, spurred by increasingly higher standards of beauty, a  30% to 50% drop in the number of cosmetic procedures performed comes as a big surprise to many plastic and cosmetic surgeons. Many of them have boasted annual incomes in the seven-figure range. Dr. Mark Sultan, plastics chief at Beth Israel Medical Center, earned $4.1 million in 2006. That made him the second-highest-paid doctor on the payroll of any New York City hospital, according to a 2008 Crain’s Health Pulse survey of hospital salaries.

After seeing his cosmetic business shrivel by 20%, Dr. Steven Pearlman, who operates at Lenox Hill Hospital in New York says, “For the first time ever, I sent out “To my loyal patients’ discount cards”.  

In a city that has long been driven by Wall Street money, Park Avenue facial specialist Dr. Yael Halaas has come up with a spiel that fits with that ethos. “We’re telling people it’s a great time to invest money in yourself [with cosmetic surgery],”she says.

Laser Offers story of the day: Surgery on sale

Consumer wants to deal with a medical aesthetic professional who specializes in aesthetic and cosmetic procedures and:

• has experience in the fine arts and appreciates the fine nuances of balance and proportion
• understands that changes in millimeters can create profound changes in facial beauty and harmony
• recognizes that the face of today is youthful and defined, never overdone or stylized
• works with each patient individually to achieve a result that enhances each person, creating a revitalized and rejuvenated self
• delivers the best results that do not look “surgical” and with minimal down time
• specializes in the most advanced and innovative techniques available today

Not easy, hah?